A8365812
Vigabatrin , ≥98% , 60643-86-9
Synonym(s):
(±)-γ-Vinyl-GABA;(±)-4-Aminohexenoic acid;(±)-Vigabatrin;(R,S)-4-Amino-5-hexenoic acid
CAS NO.:60643-86-9
Empirical Formula: C6H11NO2
Molecular Weight: 129.16
MDL number: MFCD00274577
EINECS: 637-414-1
| Pack Size | Price | Stock | Quantity |
| 10MG | RMB511.20 | In Stock |
|
| 50MG | RMB1999.20 | In Stock |
|
| 100mg | RMB3198.40 | In Stock |
|
| 250mg | RMB5596.80 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 209° |
| Flash point: | 9℃ |
| storage temp. | Desiccate at +4°C |
| solubility | Freely soluble in water, slightly soluble in methanol, practically insoluble in methylene chloride. |
| form | liquid |
| InChI | InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9) |
| InChIKey | PJDFLNIOAUIZSL-UHFFFAOYSA-N |
| SMILES | C(N)(C=C)CCC(=O)O |
| CAS DataBase Reference | 60643-86-9(CAS DataBase Reference) |
Description and Uses
Vigabatrin, the gamma-vinyl derivative of GABA, is a new anticonvulsant reportedly effective in the treatment of intractable seizures unresponsive to currently available therapy. Mechanistically vigabatrin is a potent irreversible GABA aminotransferase inhibitor which modifies the enzyme's active-site by Michael addition. Other potential indications have been suggested for vigabatrin, including depression and schizophrenia.
antibiotic
Safety
| Symbol(GHS) | ![]() ![]() ![]() GHS02,GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H225-H301+H311+H331-H370 |
| Precautionary statements | P210-P260-P280-P301+P310-P311 |
| Hazard Codes | Xi,T,F |
| Risk Statements | 36/37/38-39/23/24/25-23/24/25-11 |
| Safety Statements | 26-36-45-36/37-16-7 |
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution |
| WGK Germany | 2 |
| RTECS | MP7745000 |
| Toxicity | LD50 i.p. in mice: >2500 mg/kg (Lscher) |








